Skip to main content
. 2024 May 15;15:1399438. doi: 10.3389/fimmu.2024.1399438

Figure 3.

Figure 3

Antibodies and nanobodies differ in their structural features. Camelid nanobodies (VHHs) are derived from heavy-chain antibodies and lack the light-chain partner seen in conventional antibodies, exposing residues that would otherwise be buried at the VH-VL interface.